Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ADPT | US
0.38
7.39%
Healthcare
Biotechnology
30/06/2024
04/10/2024
5.52
5.19
5.55
5.04
Adaptive Biotechnologies Corporation a commercial-stage company develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ a platform and core immunosequencing product that is used to answer translational research questions as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers. In addition the company offers a pipeline of clinical products and services that are used for the diagnosing monitoring and treatment of diseases such as cancer and autoimmune disorders. It offers products and services for life sciences research clinical diagnostics and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech Inc. for the development manufacture and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle Washington.
View LessPositive Momentum
Strength based on increasing price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
134.8%1 month
94.6%3 months
81.8%6 months
81.3%-
-
3.05
0.94
0.39
-1.00
3.20
-
-164.10M
814.05M
814.05M
-
-92.88
-
-11.70
-67.01
9.68
8.39
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.57
Range1M
1.57
Range3M
2.23
Rel. volume
1.11
Price X volume
6.90M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Zymeworks Inc | ZYME | Biotechnology | 12.57 | 893.07M | 1.45% | n/a | 4.94% |
Applied Therapeutics Inc | APLT | Biotechnology | 7.7 | 884.31M | -8.22% | n/a | 0.30% |
Cronos Group Inc | CRON | Biotechnology | 2.24 | 856.31M | 3.70% | n/a | 0.19% |
iShares $ Corp Bond ETF USD Dist | LQDA | Biotechnology | 10.03 | 846.31M | 0.25% | n/a | 4.70% |
CARGO Therapeutics Inc. Common Stock | CRGX | Biotechnology | 17.77 | 815.72M | -1.44% | n/a | 6.45% |
Nuvation Bio Inc | NUVB | Biotechnology | 2.41 | 806.82M | 9.05% | n/a | 112.61% |
Immunome Inc | IMNM | Biotechnology | 13.17 | 790.92M | -2.44% | n/a | 1.09% |
89bio Inc | ETNB | Biotechnology | 7.19 | 772.52M | -0.96% | n/a | 5.31% |
Capricor Therapeutics Inc | CAPR | Biotechnology | 21.65 | 765.05M | 31.05% | n/a | 45.32% |
TNGX | TNGX | Biotechnology | 6.98 | 747.87M | -0.85% | n/a | 15.28% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.00 | 0.76 | Cheaper |
Ent. to Revenue | 3.20 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 3.05 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 81.83 | 74.67 | Par |
Debt to Equity | 0.94 | -1.82 | Expensive |
Debt to Assets | 0.39 | 0.26 | Expensive |
Market Cap | 814.05M | 3.73B | Emerging |